CDX2 and cancer: After analyzing the data collected from 192 independent studies (98,209 cancer-free controls and 78,628 cases), [252] it was shown that Fok1, Bsm1, Cdx2, Apa1, and Taq1 are good markers for CRC, lung, ovarian, skin, multiple myeloma, and brain tumors [252].